GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Distribution » Cardinal Health Inc (NYSE:CAH) » Definitions » ROE %

Cardinal Health (Cardinal Health) ROE %

: Negative Equity% (As of Dec. 2023)
View and export this data going back to 1994. Start your Free Trial

ROE % is calculated as Net Income divided by its average Total Stockholders Equity over a certain period of time. Cardinal Health's annualized net income for the quarter that ended in Dec. 2023 was $1,412 Mil. Cardinal Health's average Total Stockholders Equity over the quarter that ended in Dec. 2023 was $-3,470 Mil. Therefore, Cardinal Health's annualized ROE % for the quarter that ended in Dec. 2023 was Negative Equity%.

The historical rank and industry rank for Cardinal Health's ROE % or its related term are showing as below:

CAH' s ROE % Range Over the Past 10 Years
Min: -172.46   Med: 19.24   Max: Negative Equity
Current: Negative Equity

During the past 13 years, Cardinal Health's highest ROE % was Negative Equity%. The lowest was -172.46%. And the median was 19.24%.

CAH's ROE % is ranked better than
98.95% of 95 companies
in the Medical Distribution industry
Industry Median: 7.24 vs CAH: Negative Equity

Cardinal Health ROE % Historical Data

The historical data trend for Cardinal Health's ROE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Cardinal Health Annual Data
Trend Jun14 Jun15 Jun16 Jun17 Jun18 Jun19 Jun20 Jun21 Jun22 Jun23
ROE %
Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 22.01 -91.07 34.13 -172.46 Negative Equity

Cardinal Health Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
ROE % Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - Negative Equity - Negative Equity Negative Equity

Competitive Comparison

For the Medical Distribution subindustry, Cardinal Health's ROE %, along with its competitors' market caps and ROE % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Cardinal Health ROE % Distribution

For the Medical Distribution industry and Healthcare sector, Cardinal Health's ROE % distribution charts can be found below:

* The bar in red indicates where Cardinal Health's ROE % falls into.



Cardinal Health ROE % Calculation

Cardinal Health's annualized ROE % for the fiscal year that ended in Jun. 2023 is calculated as

ROE %=Net Income (A: Jun. 2023 )/( (Total Stockholders Equity (A: Jun. 2022 )+Total Stockholders Equity (A: Jun. 2023 ))/ count )
=261/( (-709+-2852)/ 2 )
=261/-1780.5
=Negative Equity %

Cardinal Health's annualized ROE % for the quarter that ended in Dec. 2023 is calculated as

ROE %=Net Income (Q: Dec. 2023 )/( (Total Stockholders Equity (Q: Sep. 2023 )+Total Stockholders Equity (Q: Dec. 2023 ))/ count )
=1412/( (-3491+-3449)/ 2 )
=1412/-3470
=Negative Equity %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of annual ROE %, the net income of the last fiscal year and the average total shareholder equity over the fiscal year are used. In calculating the quarterly data, the net income data used here is four times the quarterly (Dec. 2023) net income data. ROE % is displayed in the 30-year financial page.

* Note that if the average Total Stockholders Equity is zero or negative, then ROE % would be considered meaningless and hence not be calculated.


Cardinal Health  (NYSE:CAH) ROE % Explanation

ROE % measures the rate of return on the ownership interest (shareholder's equity) of the common stock owners. It measures a firm's efficiency at generating profits from every unit of shareholders' equity (also known as net assets or assets minus liabilities). ROE % shows how well a company uses investment funds to generate earnings growth. ROE %s between 15% and 20% are considered desirable.

The factors that affect a company's ROE % can be illustrated with the three-step DuPont Analysis:

ROE %(Q: Dec. 2023 )
=Net Income/Total Stockholders Equity
=1412/-3470
=(Net Income / Revenue )*(Revenue / Total Assets)*(Total Assets / Total Stockholders Equity)
=(1412 / 229780)*(229780 / 45141.5)*(45141.5 / -3470)
=Net Margin %*Asset Turnover*Equity Multiplier
=0.61 %*5.0902*N/A
=ROA %*Equity Multiplier
=3.11 %*N/A
=Negative Equity %

With this breakdown, it is clear that if a company grows its Net Profit Margin, its Asset Turnover, or its Leverage, it can grow its ROE %.

The factors that affect a company's ROE % can also be illustrated with the five-step DuPont Analysis:

ROE %(Q: Dec. 2023 )
=Net Income/Total Stockholders Equity
=1412/-3470
=(Net Income / Pre-Tax Income) * (Pre-Tax Income / Operating Income) * (Operating Income / Revenue) * (Revenue / Total Assets) * (Total Assets / Total Stockholders Equity)
= (1412 / 1960) * (1960 / 2000) * (2000 / 229780) * (229780 / 45141.5) * (45141.5 / -3470)
= Tax Burden * Interest Burden * Operating Margin % * Asset Turnover * Equity Multiplier
= 0.7204 * 0.98 * 0.87 % * 5.0902 * N/A
=Negative Equity %

Note: The net income data used here is four times the quarterly (Dec. 2023) net income data. The Revenue data used here is four times the quarterly (Dec. 2023) revenue data. The same rule applies to Pre-Tax Income and Operating Income.
* In the five-step DuPont Analysis, Operating Income is only available for non-financial companies. Thus, for Insurance companies, we use EBIT as a substitution of Operating Income. For Banks, both Operating Income and EBIT is unavailable. Thus we combined Interest Burden and Operating Margin % into Pretax Margin %, and the DuPont Analysis is divided into four components instead.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Be Aware

Net Income is used.

Because a company can increase its ROE % by having more financial leverage, it is important to watch the equity multiplier when investing in high ROE % companies. Like ROA %, ROE % is calculated with only 12 months data. Fluctuations in company's earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective.

Asset light businesses require very few assets to generate very high earnings. Their ROE %s can be extremely high.


Cardinal Health ROE % Related Terms

Thank you for viewing the detailed overview of Cardinal Health's ROE % provided by GuruFocus.com. Please click on the following links to see related term pages.


Cardinal Health (Cardinal Health) Business Description

Address
7000 Cardinal Place, Dublin, OH, USA, 43017
Cardinal Health is one of three leading pharmaceutical wholesalers in the U.S., engaged in sourcing and distributing of branded, generic, and specialty pharmaceutical products to pharmacies (retail chains, independent, and mail order), hospitals networks, and healthcare providers. Along with Cencora and McKesson, the three comprise well over 90% of the U.S. pharmaceutical wholesale industry. Cardinal Health also supplies medical-surgical products and equipment to healthcare facilities in North America, Europe, and Asia.
Executives
Deborah Weitzman officer: CEO, Pharmaceutical Segment 600 WEST 22ND STREET, SUITE 300, OAK BROOK IL 60523
Mary C. Scherer officer: Chief Accounting Officer 6026 LUDWIG STREET, POWELL OH 43065
Ola M Snow officer: Chief Human Resources Officer 7000 CARDINAL PLACE, DUBLIN OH 43017
Stephen M Mason officer: CEO, Medical Segment 7000 CARDINAL PLACE, DUBLIN OH 43017
Jessica L Mayer officer: Chief Legal/Compliance Officer 7000 CARDINAL PLACE, DUBLIN OH 43017
Michelle D. Greene officer: Chief Information Officer 1141 N. OLD WORLD 3RD STREET, UNIT # 2414, MILWAUKEE WI 53203
Aaron E Alt officer: Chief Financial Officer 3001 COLORADO BLVD., DENTON TX 76210
Michelle Brennan director 1855 S. GRANT STREET, SAN MATEO CA 94402
Sujatha Chandrasekaran director 77 HOT METAL STREET, PITTSBURGH PA 15203
Christine Mundkur director
Steven Barg director ELLIOTT MANAGEMENT CORPORATION, 40 WEST 57TH STREET, NEW YORK NY 10019
Patricia M English officer: Chief Accounting Officer 7000 CARDINAL PLACE, DUBLIN OH 43017
Sheri H. Edison director 1069 STATE ROUTE 46 EAST, BATESVILLE IN 47006
Jason M. Hollar officer: Chief Financial Officer 3333 BEVERLY ROAD, HOFFMAN ESTATES IL 60179
John H Weiland director C/O C.R BARD INC, 730 CENTRAL AVE, MURRAY HILL NJ 07974

Cardinal Health (Cardinal Health) Headlines